HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Drug Pipeline
RCT
Tezepelumab significantly improved smell and taste scores in adults with chronic rhinosinusitis with nasal polyps over fifty-two weeks of treatment
New drug restores smell for chronic sinusitis patients quickly
In a Phase 3 trial, tezepelumab demonstrated superior efficacy over placebo for improving smell and taste in adults with uncontrolled chroni…
A new drug helps people with chronic sinusitis regain their sense of smell much faster than standard treatments allow
May 6, 2026
Allergy & Immunology
Meta-analysis
Switching Biologics in Severe Asthma Patients Shows Improved Clinical Outcomes and Reduced Exacerbations Across Multiple Therapies
Switching Asthma Drugs Could Change Your Life
A systematic review and meta-analysis of 2,292 patients found that switching biologics significantly reduced exacerbations and improved asth…
If your severe asthma medication stops working, switching to a different biologic drug could cut your attacks in half and help you breathe e…
May 5, 2026
Drug Pipeline
Sys. Review
Narrative review discusses tezepelumab for severe asthma in type 2-low patients on GINA Step 4–5 therapy
New Asthma Drug Works for Hard-to-Treat Patients Who Had Few Options
This narrative review examines tezepelumab for severe asthma, specifically focusing on type 2-low patients currently prescribed GINA Step 4–…
This new treatment offers hope for severe asthma patients who don’t respond to standard therapies, including a group previously left out of …
Frontiers
Apr 24, 2026